Author

Alexander B. Radaoui

Children's Hospital of PhiladelphiaORCID 0000-0001-5179-7169Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alberto DelaidelliiD· 1 shared Amber K. WeineriD· 1 shared Apexa ModiiD· 1 shared Benjamin A. GarciaiD· 1 shared Beverly A. TeicheriD· 1 shared Bo ZhangiD· 1 shared Brian EnnisiD· 1 shared Bruce PaweliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto DelaidelliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedOct 24, 2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Amber K. Weiner, Alexander B. Radaoui, Matthew Tsang…·Sharon J. Diskin

This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.

28 citationstop 3%

humanproteomics

𝕏 PostBluesky